• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡咯里西啶生物碱诱导的肝窦阻塞综合征的 CT 增强扫描诊断性能。

Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.

机构信息

Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.

出版信息

Sci Rep. 2016 Nov 29;6:37998. doi: 10.1038/srep37998.

DOI:10.1038/srep37998
PMID:27897243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5126558/
Abstract

Hepatic sinusoidal obstruction syndrome (HSOS) can be caused by pyrrolizidine alkaloids(PAs)-containing herbals. Since PAs exposure is obscure and clinical presentation of HSOS is unspecific, it is challenge to establish the diagnosis of PAs-induced HSOS. Gynura segetum is one of the most wide-use herbals containing PAs. The aim of our study is to describe the features of contrast-enhanced computed tomography (CT) in gynura segetum-induced HSOS, and then determine diagnostic performance of radiological signs. We retrospectively analyzed medical records and CT images of HSOS patients (71 cases) and the controls (222 cases) enrolled from January 1, 2008, to Oct 31, 2015. The common findings of contrast CT in PAs-induced HSOS included: ascites (100%), hepatomegaly (78.87%), gallbladder wall thickening (86.96%), pleural effusion (70.42%), hepatic vein narrowing (87.32%), patchy liver enhancement (92.96%), and heterogeneous hypoattenuation (100%); of these signs, patchy enhancement and heterogeneous hypoattenuation were valuable features. Then, the result of diagnostic performance demonstrated that contrast CT possessed better performance in diagnosing PAs-induced HSOS compared with various parameters of Seattle criteria. In conclusion, the patients with PAs-induced HSOS display distinct radiologic features at CT-scan, which reveals that contrast-enhanced CT provides an effective noninvasive method for diagnosing PAs-induced HSOS.

摘要

肝窦阻塞综合征(HSOS)可由含吡咯里西啶生物碱(PAs)的草药引起。由于 PAs 暴露不明确,且 HSOS 的临床表现不特异,因此建立 PAs 诱导的 HSOS 的诊断具有挑战性。三叶鬼针草是最广泛使用的含 PAs 草药之一。本研究旨在描述三叶鬼针草诱导的 HSOS 的增强 CT 特征,并确定影像学征象的诊断性能。我们回顾性分析了 2008 年 1 月 1 日至 2015 年 10 月 31 日期间 HSOS 患者(71 例)和对照组(222 例)的病历和 CT 图像。PAs 诱导的 HSOS 患者增强 CT 的常见表现包括:腹水(100%)、肝肿大(78.87%)、胆囊壁增厚(86.96%)、胸腔积液(70.42%)、肝静脉狭窄(87.32%)、斑片状肝增强(92.96%)和不均匀低衰减(100%);其中,斑片状增强和不均匀低衰减是有价值的特征。然后,诊断性能的结果表明,与西雅图标准的各种参数相比,增强 CT 对诊断 PAs 诱导的 HSOS 具有更好的性能。总之,PAs 诱导的 HSOS 患者 CT 扫描显示出明显的放射学特征,这表明增强 CT 为诊断 PAs 诱导的 HSOS 提供了一种有效的非侵入性方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c34/5126558/a4bf5c753428/srep37998-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c34/5126558/f7cb50471786/srep37998-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c34/5126558/3c53fdfa5c48/srep37998-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c34/5126558/5241b3a6767e/srep37998-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c34/5126558/a4bf5c753428/srep37998-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c34/5126558/f7cb50471786/srep37998-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c34/5126558/3c53fdfa5c48/srep37998-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c34/5126558/5241b3a6767e/srep37998-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c34/5126558/a4bf5c753428/srep37998-f4.jpg

相似文献

1
Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.吡咯里西啶生物碱诱导的肝窦阻塞综合征的 CT 增强扫描诊断性能。
Sci Rep. 2016 Nov 29;6:37998. doi: 10.1038/srep37998.
2
Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.吡咯里西啶生物碱诱导的肝窦阻塞综合征的临床特征、CT表现及病理结果:一项回顾性研究
BMC Gastroenterol. 2020 Feb 4;20(1):30. doi: 10.1186/s12876-020-1180-0.
3
Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features.草药相关性肝窦阻塞综合征:CT 和 MRI 特征。
Korean J Radiol. 2014 Mar-Apr;15(2):218-25. doi: 10.3348/kjr.2014.15.2.218. Epub 2014 Mar 7.
4
Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.吡咯里西啶生物碱诱导的肝窦阻塞综合征:发病机制、临床表现、诊断、治疗和结局。
World J Gastroenterol. 2019 Jul 28;25(28):3753-3763. doi: 10.3748/wjg.v25.i28.3753.
5
Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.吡咯里西啶生物碱所致肝窦阻塞综合征的明确诊断。
J Dig Dis. 2012 Jan;13(1):33-9. doi: 10.1111/j.1751-2980.2011.00552.x.
6
Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function.吡咯里西啶生物碱诱导的肝窦阻塞综合征的钆塞酸增强肝胆期磁共振成像及与肝功能的关系。
Sci Rep. 2019 Feb 4;9(1):1231. doi: 10.1038/s41598-018-37775-1.
7
Tusanqi and hepatic sinusoidal obstruction syndrome.土三七和肝窦阻塞综合征。
J Dig Dis. 2014 Mar;15(3):105-7. doi: 10.1111/1751-2980.12112.
8
Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.与食用菊三七相关的肝窦阻塞综合征。
J Hepatol. 2011 Apr;54(4):666-73. doi: 10.1016/j.jhep.2010.07.031. Epub 2010 Sep 22.
9
Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome.血中吡咯-蛋白质加合物作为吡咯里西啶生物碱致肝窦阻塞综合征的诊断和预后指标
Drug Des Devel Ther. 2015 Aug 25;9:4861-8. doi: 10.2147/DDDT.S87858. eCollection 2015.
10
Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate.菊三七相关肝窦阻塞综合征:一种高死亡率和误诊率的肝脏疾病。
Curr Pharm Des. 2019;25(35):3762-3768. doi: 10.2174/1381612825666191007162024.

引用本文的文献

1
Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report.胃癌合并肝窦阻塞综合征的根治性全胃切除术:1例病例报告
Front Med (Lausanne). 2025 May 9;12:1544400. doi: 10.3389/fmed.2025.1544400. eCollection 2025.
2
Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives.药物性肝窦阻塞综合征:当前进展与未来展望
Arch Toxicol. 2025 Mar;99(3):835-850. doi: 10.1007/s00204-024-03950-9. Epub 2024 Dec 24.
3
Gynura segetum induces hepatic sinusoidal obstruction syndrome in a child: A case report.

本文引用的文献

1
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.成人患者窦性阻塞综合征/静脉闭塞性疾病的修订诊断和严重程度标准:欧洲血液和骨髓移植学会的新分类
Bone Marrow Transplant. 2016 Jul;51(7):906-12. doi: 10.1038/bmt.2016.130. Epub 2016 May 16.
2
Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome.血中吡咯-蛋白质加合物作为吡咯里西啶生物碱致肝窦阻塞综合征的诊断和预后指标
Drug Des Devel Ther. 2015 Aug 25;9:4861-8. doi: 10.2147/DDDT.S87858. eCollection 2015.
3
《菊三七致儿童肝窦阻塞综合征 1 例报告》。
Medicine (Baltimore). 2024 Mar 15;103(11):e37341. doi: 10.1097/MD.0000000000037341.
4
Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi - Case report and literature review.土三七致肝窦阻塞综合征的临床病理特征及诊断——病例报告并文献复习
Open Med (Wars). 2023 Jun 12;18(1):20230737. doi: 10.1515/med-2023-0737. eCollection 2023.
5
Hepatic Venous Occlusion Type of Budd-Chiari Syndrome versus Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstructive Syndrome: A Multi-Center Retrospective Study.布加综合征的肝静脉闭塞型与吡咯烷生物碱诱导的肝窦阻塞综合征:一项多中心回顾性研究
J Pers Med. 2023 Mar 30;13(4):603. doi: 10.3390/jpm13040603.
6
Multiparametric MRI with MR elastography findings in patients with sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy.基于奥沙利铂化疗后出现窦性阻塞综合征患者的多参数磁共振成像及磁共振弹性成像结果
Insights Imaging. 2022 Sep 5;13(1):147. doi: 10.1186/s13244-022-01281-w.
7
Difference between type 2 gastroesophageal varices and isolated fundic varices in clinical profiles and portosystemic collaterals.2型胃食管静脉曲张与孤立性胃底静脉曲张在临床特征和门体侧支循环方面的差异。
World J Clin Cases. 2022 Jun 16;10(17):5620-5633. doi: 10.12998/wjcc.v10.i17.5620.
8
Interventional Management of Portal Hypertension in Cancer Patients.癌症患者门静脉高压的介入治疗管理。
Curr Oncol Rep. 2022 Nov;24(11):1461-1475. doi: 10.1007/s11912-022-01319-8. Epub 2022 Aug 12.
9
Clinical Features and CT Imaging Analysis of Hepatic Sinuscase-Syndrome and Budd-Chiari Syndrome.肝窦综合征与布加综合征的临床特征及CT影像分析
Int J Gen Med. 2022 Mar 2;15:2389-2396. doi: 10.2147/IJGM.S348176. eCollection 2022.
10
Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy.绞股蓝通过损害自噬诱导小鼠肝窦阻塞综合征。
Acta Cir Bras. 2022 Feb 18;36(11):e361104. doi: 10.1590/ACB361104. eCollection 2022.
Tusanqi-Related Sinusoidal Obstruction Syndrome in China: A Systematic Review of the Literatures.
中国土三七相关肝窦阻塞综合征:文献系统评价
Medicine (Baltimore). 2015 Jun;94(23):e942. doi: 10.1097/MD.0000000000000942.
4
Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation.肝移植后与他克莫司相关的可逆性窦性阻塞综合征
World J Gastroenterol. 2015 May 28;21(20):6422-6. doi: 10.3748/wjg.v21.i20.6422.
5
Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites.肿瘤标志物在良恶性腹水鉴别诊断中的评价。
Ann Hepatol. 2014 May-Jun;13(3):357-63.
6
Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features.草药相关性肝窦阻塞综合征:CT 和 MRI 特征。
Korean J Radiol. 2014 Mar-Apr;15(2):218-25. doi: 10.3348/kjr.2014.15.2.218. Epub 2014 Mar 7.
7
Tusanqi and hepatic sinusoidal obstruction syndrome.土三七和肝窦阻塞综合征。
J Dig Dis. 2014 Mar;15(3):105-7. doi: 10.1111/1751-2980.12112.
8
Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid--enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation.胃肠道恶性肿瘤患者化疗诱导性局灶性肝病变:与临床病理相关性的钆塞酸增强及弥散加权 MR 成像。
Radiology. 2014 May;271(2):416-25. doi: 10.1148/radiol.13131810. Epub 2014 Jan 16.
9
Management of hepatic vascular diseases.肝脏血管疾病的管理。
J Hepatol. 2012;56 Suppl 1:S25-38. doi: 10.1016/S0168-8278(12)60004-X.
10
Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.吡咯里西啶生物碱所致肝窦阻塞综合征的明确诊断。
J Dig Dis. 2012 Jan;13(1):33-9. doi: 10.1111/j.1751-2980.2011.00552.x.